Wells Fargo’s CoLucid Pharmaceuticals, Inc. CLCD Stock Holding History

Wells Fargo’s Portfolio CLCD Stock Details CLCD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-4,447	Closed	-$161K	–	6720
2016 Q4	$161K	Sell	4,447 -822	-16%	-$29.1K	﹤0.01%	4886
2016 Q3	$201K	Buy	+5,269	New	+$77.9K	﹤0.01%	4485

Other funds holding CLCD

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Wells Fargo's CLCD Position: Q1 2017 in Review

Wells Fargo sold out of CoLucid Pharmaceuticals, Inc. (CLCD) in Q1 2017, closing a stake of 4,447 shares — an estimated $161K sold.

Wells Fargo first reported a position in CLCD in Q3 2016 and held it in 2 quarters. The position peaked at $201K in Q3 2016. 1 fund tracked by Wall St. Rank holds CLCD as of Q1 2017.

Wells Fargo reported no remaining CoLucid Pharmaceuticals, Inc. position as of Q1 2017 after selling out during the quarter.
Wells Fargo sold 4,447 CoLucid Pharmaceuticals, Inc. shares in Q1 2017, an estimated $161K.
Wells Fargo first reported a position in CoLucid Pharmaceuticals, Inc. in Q3 2016 and held it in 2 quarters.
Wells Fargo's CoLucid Pharmaceuticals, Inc. position peaked at $201K in Q3 2016.
1 fund tracked by Wall St. Rank held CoLucid Pharmaceuticals, Inc. as of Q1 2017.

Based on Wells Fargo's 13F filing for Q1 2017, filed 28 Apr 2017.